|
⚲
|
| Keyboard |
| Quan Lucinda Y
✚
|
|
|---|---|
| CIK # | 0001824711 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001824711] | |
| 4 | [0001824711] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aligos Therapeutics Inc | |
| Quan Lucinda Y |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2023-09-08 | Grant | 48,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2023-03-15 | Grant | 78,750 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2022-07-07 | Grant | 52,500 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2022-02-04 | Grant | 105,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2022-02-04 | Grant | 26,250 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2020-12-01 | Grant | 200,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 6,835 | ||
|
Aligos Therapeutics Inc ALGS
Series A Preferred Stock · derivative
|
2020-10-20 | Conversion | 6,835 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series B-2 Preferred Stock · derivative
|
2020-10-20 | Conversion | 726 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series B-1 Preferred Stock · derivative
|
2020-10-20 | Conversion | 1,697 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 1,697 | ||
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 726 |